{"name":"Susan Bal","slug":"susan-bal","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNSzAwSnFNMUZWREhWRVZTNVNoeExiOHJTSk9qWVdrVjlSTDg2dk43Ui0wMVZEWW5PamZsTF9FUnRVTmVnYkNIdjNLRmRnX3c2eTdzRmx0dFU3UkVCZFBYYmgtYW5nX0RLMVJ0bDZOVHE0NjNwdlMyck9ubzhrR2J1c19qZHBZZUQ5MVJEc3g1Vzk1Z2hGbjNjaDZMbHlFaVZOWlJKNEhLV2tDcjlBQnU2WkNB?oc=5","date":"2024-12-09","type":"trial","source":"CGTLive®","summary":"Arlo-Cel Generates Excitement, Moves Quickly to Phase 3 Studies for Multiple Myeloma - CGTLive®","headline":"Arlo-Cel Generates Excitement, Moves Quickly to Phase 3 Studies for Multiple Myeloma - CGTLive®","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}